abstract |
The present invention provides a therapeutic composition for male sterility comprising an adenosine A1 receptor antagonist of formula (see formula I) or (see formula II) or a salt thereof: wherein R1, R2, A and R are as defined herein, as the active ingredient in combination with an organic or an inorganic carrier or excipient. |